Vedrana Reichenbach

595 citations
15 papers · 481 indexed · h-index 11
Topics
Apelin-related biomedical research (6 papers)Liver Disease Diagnosis and Treatment (4 papers)Liver physiology and pathology (3 papers)

In The Last Decade

Vedrana Reichenbach

15 papers receiving 471 citations

Peers

Vedrana Reichenbach
Comparison fields: 5 of 77
  • Hepatology 144
  • Epidemiology 137
  • Surgery 133
  • Pharmacology 125
  • Materials Chemistry 95
Replace Hans Ernst with:
Hans Ernst Germany
Jordi Ribera Spain
Dina H. Kassem Egypt
Tatjana Seitz Germany
Natsumi Watanabe Japan
Moonsuk Choi United States
Sayuri Nakamura Japan
Qinglin Zhang China
Tadahiro Shinozawa Japan
Nanwen Zhang China
Vedrana Reichenbach relative to Hans Ernst Germany Hans Ernst's profile →
Citations per field
00.5×10×15×20×
Hans Ernst · 1×
Citations per year

Countries citing papers authored by Vedrana Reichenbach

Since Specialization
Citations

This map shows the geographic impact of Vedrana Reichenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vedrana Reichenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vedrana Reichenbach more than expected).

Fields of papers citing papers by Vedrana Reichenbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vedrana Reichenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vedrana Reichenbach. The network helps show where Vedrana Reichenbach may publish in the future.

Co-authorship network of co-authors of Vedrana Reichenbach

This figure shows the co-authorship network connecting the top 25 collaborators of Vedrana Reichenbach. A scholar is included among the top collaborators of Vedrana Reichenbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vedrana Reichenbach. Vedrana Reichenbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 8
2 2
3 14
4 172
5 10
6 11
7 30
8 11
9 25
10 56
11 28
12 54
13 1
14 53
15 6

About Vedrana Reichenbach

Vedrana Reichenbach is a scholar working on Hepatology, Pharmacology and Applied Psychology, having authored 15 papers that have together received 481 indexed citations. Recurring topics across this work include Apelin-related biomedical research (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and Liver physiology and pathology (3 papers). The work is most often cited by research in Hepatology (144 citations), Pharmacology (125 citations) and Epidemiology (137 citations). Vedrana Reichenbach has collaborated with scholars based in Spain, United States and Denmark. Frequent co-authors include Wladimiro Jiménez, Gregori Casals, Guillermo Fernández‐Varo, Manuel Morales‐Ruiz, Pedro Melgar‐Lesmes, Denise Oró, Silvia Carvajal, Josefa Ros Velasco, Bernardino González de la Presa and Eudald Casals. Their work appears in journals such as PLoS ONE, Hepatology and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026